Scleroderma

Scleroderma

Q. 1

Diffuse cutaneous systemic sclerosis is characterised by:

 A

Early pulmonary fibrosis

 B

Raynauds phenomenon

 C

Calcinosis cutis

 D

Long term prognosis is better

Q. 1

Diffuse cutaneous systemic sclerosis is characterised by:

 A

Early pulmonary fibrosis

 B

Raynauds phenomenon

 C

Calcinosis cutis

 D

Long term prognosis is better

Ans. A

Explanation:

Diffuse cutaneous SSc is associated with 

1. Progressive skin induration
2. Early pulmonary fibrosis and acute renal involvement. 
Limited cutaneous SSc have 
1. Long-standing Raynaud’s phenomenon before other manifestations of SSc appear. 
2. Skin involvement remains limited to the fingers (sclerodactyly) 
 
A subset of patients with limited systemic sclerosis have 
a) calcinosis cutis, 
b) Raynaud’s phenomenon, 
c) esophageal dysmotility, 
d) sclerodactyly
e) telangiectasia
(Termed CREST syndrome)
Long term prognosis is poor in diffuse variety than limited systemic sclerosis.
Ref: Harrison, E-18, P- 2757.

 


Q. 2

In late stages of systemic sclerosis may have all the given features, EXCEPT:

 A

Pulmonary artery hypertension

 B

Interstitial lung diserase

 C

Primary biliary cirrhosis

 D

Primary sclerosing cholangitis

Q. 2

In late stages of systemic sclerosis may have all the given features, EXCEPT:

 A

Pulmonary artery hypertension

 B

Interstitial lung diserase

 C

Primary biliary cirrhosis

 D

Primary sclerosing cholangitis

Ans. D

Explanation:

Late stages of limited systemic sclerosis patients may develop

  • Pulmonary arterial hypertension (PAH), 
  • Interstitial lung disease, 
  • Hypothyroidism, 
  • Primary biliary cirrhosis 
 
Raynaud’s phenomenon and other typical features of systemic sclerosis occur in the absence of detectable skin thickening in some patients. This syndrome is been termed SSc sine scleroderma.
Ref: Harrison, E-18, P- 2757.

Q. 3

Limited cutaneous systemic sclerosis have the following characteristic autoantibody positivity:

 A

Anti Topoisomerase I

 B

Anti-RNA polymerase III

 C

Scl-70

 D

Anticentromere

Q. 3

Limited cutaneous systemic sclerosis have the following characteristic autoantibody positivity:

 A

Anti Topoisomerase I

 B

Anti-RNA polymerase III

 C

Scl-70

 D

Anticentromere

Ans. D

Explanation:

Subset of systemic sclerosis limited cutaneous scleroderma has the following features:

  • Skin involvement-Indolent onset and progression. Limited to fingers.
  • Raynaud’s phenomenon-Precedes skin involvement; associated with critical ischemia
  • Pulmonary artery hypertension-Frequent, late, may be isolated
  • Pulmonary fibrosis – rare
  • scleroderma renal crisis-Very rare
  • Calcinosis cutis-Frequent, prominent
  • Characteristic autoantibodies-Anti Centromere
In Diffuse systemic sclerosis Characteristic autoantibodies-Anti Topoisomerase I (Scl-70), anti-RNA polymerase III
Ref: Harrison, E-18, P- 2758.

Quiz In Between


Q. 4

All of the following statements regarding systemic sclerosis are TRUE, EXCEPT:

 A

Increased serum antibodies to human cytomegalovirus are seen

 B

Eosinophilia myalgia syndrome is a subtype of systemic sclerosis

 C

The incidence of SSc is increased among miners exposed to silica

 D

Bleomycin, pentazocine and cocaine may produce systemic sclerosis like illness

Q. 4

All of the following statements regarding systemic sclerosis are TRUE, EXCEPT:

 A

Increased serum antibodies to human cytomegalovirus are seen

 B

Eosinophilia myalgia syndrome is a subtype of systemic sclerosis

 C

The incidence of SSc is increased among miners exposed to silica

 D

Bleomycin, pentazocine and cocaine may produce systemic sclerosis like illness

Ans. B

Explanation:

Patients with systemic sclerosis:

  • Have  increased serum antibodies to human cytomegalovirus (hCMV) 
  • Evidence of human parvovirus B19 infection is seen 
  • It is more  in  miners exposed to silica.
  • It is more in polyvinyl chloride, epoxy resins, and aromatic hydrocarbons including toluene and trichloroethylene exposures. 
  • Bleomycin, pentazocine and cocaine are implicated with systemic sclerosis                                                          
  • Women with silicone breast implants-more risk                                                       
Eosinophilia-myalgia syndrome (EMS) have marked eosinophilia, severe myalgia and scleroderma-like chronic skin lesions. It is linked to the consumption of L-tryptophan used as dietary supplements.
It is not a subtype of systemic sclerosis. Similar features also seen with toxic oil syndrome.
Ref: Harrison,E-18,P- 2758.

Q. 5

Features of systemic sclerosis are –

 A

Calcinosis

 B

Sclerodactyly

 C

Raynaud’s phenomena

 D

All

Q. 5

Features of systemic sclerosis are –

 A

Calcinosis

 B

Sclerodactyly

 C

Raynaud’s phenomena

 D

All

Ans. D

Explanation:

Ans. is ‘a’ i.e., Calcinosis; ‘b’ i.e., Sclerodactyly & ‘c’ i.e., Raynaud’s phenomena

Systemic sclerosis (scleroderma)

  • Systemic sclerosis is a chronic disease of unknown etiology characterized by abnormal accumulation of fibrous tissue in skin and multiple organs.
  • Systemic sclerosis is primarily a disease of female.

o The most common age is 30-50 years.                                                                  

(Note – Robbin’s has given 50-60 years. I went through many other books and various articles. According to them the age group is 30-50 years).

o It is characterized by excessive fibrosis throughout the body.

o The skin is most commonly affected, but the GIT, kidney, heart, muscles and lungs also are involved. Classification

  • Systemic sclerosis (scleroderma) has been classified into two major categories –

1.Diffuse scleroderma

o Wide spread skin involvement at onset.

  • Rapid progression and early skin involvement.

2. Limited scleroderma

  • Skin involvement is confined to fingers, forearm and face.

o Visceral involvement is late.

  • Progression is slow and relatively benign.
  • Some patients with limited disease also develop a combination of calcinosis, sclerodactyly, Raynaud phenomenon, Esophageal dysmotility, Sclerodactyly and telengectasis, called the CREST syndrome. Note ‑

o Calcinosis                                        –> Subcutaneous calcification of finger and along extensor surface of forearm.

o Raynaud phenomenon                       —> Episodic vasoconstriction of arteries and arterioles of the extremities.

o Sclerodactyly                                    –> Skin fibrosis and thickening limited to fingers and toes.

o Telengectasis                                  —> Dilated capillaries.


Q. 6

All of the following features about generalized (diffuse) systemic sclerosis are true, Except:

 A

Raynaud’s phenomenon seen years before skin changes

 B

Trunk involvement

 C

Anti centromere antibodies are characteristic

 D

Frequent systemic symptoms

Q. 6

All of the following features about generalized (diffuse) systemic sclerosis are true, Except:

 A

Raynaud’s phenomenon seen years before skin changes

 B

Trunk involvement

 C

Anti centromere antibodies are characteristic

 D

Frequent systemic symptoms

Ans. C

Explanation:

Answer is C (Anticentromere antibodies are characteristic):

Antitopoisomerase antibodies (Scl 70) are characteristic of diffuse systemic sclerosis and not Anticentromere antibodies.

Subsets of systemic sclerosis (SSC): Limited cutaneous SSC versus diffuse cutaneous:

Features

Limited cutaneous SSc

Diffuse cutaneous SSc

Skin involvement

Limited to fingers, distal to elbows, face; slow

progression

Diffuse: finger, extremities, face, trunk; rapid

progression

Raynaud’s phenomenon

Preceds skin involvement; associated with

critical ischemia

Onset contemporaneous with skin involvement

Pulmonary fibrosis

May occur, moderate

Frequent, early and severe

Pulmonary arterial

hypertension

Frequent, late, may be isolated

May occur, associated with pulmonary fibrosis

Scleroderma renal crisis

Very rare

Occurs in 15%; early

Calcinosis cutis

Frequent, prominent

May occur, mild

Characteristic

autoantibodies

Anticentromere

Antitopoisomerase (Scl – 70)

Systemic symptoms

Infrequent systemic symptoms such as

Arthralgias, weight loss and pulmonary

symptoms

Significant systemic symptoms such as

Arthralgias, weight loss and tendon friction rubs


Q. 7

Features of systemic sclerosis include all of the following, Except:

 A

Calcinosis

 B

Sclerodactyly

 C

Hyperpigmentation (Melanin deposition)

 D

More common in young patients

Q. 7

Features of systemic sclerosis include all of the following, Except:

 A

Calcinosis

 B

Sclerodactyly

 C

Hyperpigmentation (Melanin deposition)

 D

More common in young patients

Ans. D

Explanation:

Answer is D (More common in young patients):

Systemic sclerosis is primarily a disease of adults and the mean age of presentation is around 50 years.

Systemic sclerosis is not a disease of young individuals

The mean age of presentation of systemic sclerosis is 50 years — Current Diagnosis & Treatment in Rheumatology 2nd/228 The peak incidence of systemic sclerosis is 50-60 years — Robbins 7th/239

The most common age of onset in the range of 30-50 years — Harrison 171h/2097

Systemic sclerosis is more common in women

Like other connective tissue disorders systemic sclerosis shows a female predominance- Harrison 17th/2097 Systemic sclerosis is primarily a disease of women (female to male ratio is 3: I) — Robbin,s

Systemic sclerosis may present with Calcinosis, Sclerodactyly and hyperpiamentation

The skin of extremities and trunk may be darkly pigmented. Diffuse tanning in the absence of sun exposure may be a very early manifestation of skin involvement — Harrisons

Calcinosis and sclerodactyly are part of the ‘Crest syndrome’ in limited systemic sclerosis

 

CREST syndrome

C

Calcinosis

R

Raynauld’s

E

Esophageal dysmotility

S

Sclerodactyly

T

Telengactasia


Quiz In Between



Leave a Reply

Discover more from New

Subscribe now to keep reading and get access to the full archive.

Continue reading

👨‍⚕️
Chat Support